STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 5.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $880,000 | +62.7% | 68,446 | +20.2% | 0.00% | 0.0% |
| Q4 2018 | $541,000 | -68.6% | 56,943 | -45.2% | 0.00% | 0.0% |
| Q3 2018 | $1,724,000 | +105.0% | 103,844 | +98.2% | 0.00% | 0.0% |
| Q2 2018 | $841,000 | +26.7% | 52,395 | +20.7% | 0.00% | 0.0% |
| Q1 2018 | $664,000 | -1.9% | 43,397 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $677,000 | +40.5% | 43,397 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $482,000 | +20.8% | 43,397 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $399,000 | +9.0% | 43,397 | +1.3% | 0.00% | 0.0% |
| Q1 2017 | $366,000 | -2.9% | 42,856 | +21.8% | 0.00% | 0.0% |
| Q4 2016 | $377,000 | +29.6% | 35,195 | +30.8% | 0.00% | – |
| Q3 2016 | $291,000 | +87.7% | 26,913 | +17.8% | 0.00% | – |
| Q2 2016 | $155,000 | +46.2% | 22,853 | 0.0% | 0.00% | – |
| Q1 2016 | $106,000 | -26.4% | 22,853 | 0.0% | 0.00% | – |
| Q4 2015 | $144,000 | -28.7% | 22,853 | 0.0% | 0.00% | – |
| Q3 2015 | $202,000 | -24.9% | 22,853 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $269,000 | -15.4% | 22,853 | +4.1% | 0.00% | 0.0% |
| Q1 2015 | $318,000 | +13.2% | 21,955 | +33.4% | 0.00% | 0.0% |
| Q4 2014 | $281,000 | +37.1% | 16,452 | 0.0% | 0.00% | – |
| Q3 2014 | $205,000 | -14.9% | 16,452 | 0.0% | 0.00% | – |
| Q2 2014 | $241,000 | -22.5% | 16,452 | +7.6% | 0.00% | -100.0% |
| Q1 2014 | $311,000 | +24.4% | 15,284 | +19.7% | 0.00% | 0.0% |
| Q4 2013 | $250,000 | -56.7% | 12,764 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $578,000 | +102.1% | 12,764 | +6.3% | 0.00% | 0.0% |
| Q2 2013 | $286,000 | – | 12,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|